Introduction: Metabolic control of phenylketonuria (PKU) and compliance with the low-phenylalanine (phe) diet are frequently assessed by measuring blood phe concentrations in dried blood spots (DBS) collected by patients instead of plasma phe concentrations. Objective: Our objective was to investigate the difference in blood phe concentrations in DBS collected by subjects and analyzed using either a validated newborn screening tandem mass spectrometry (MS/MS) protocol or ion-exchange chromatography (IEC) compared to plasma phe concentrations obtained simultaneously and analyzed using IEC. Design: Three to four fasting blood samples were obtained from 29 subjects with PKU, ages 15–49 years. Capillary blood was spotted on filter paper by each...
Background: This study investigated the agreement between various dried blood spot (DBS) and venous ...
Background/Aims: In patients with phenylketonuria (PKU), target ranges of blood phenylalanine (Phe) ...
International audienceBACKGROUND:Different pathophysiological mechanisms have been described in phen...
Monitoring phenylalanine (Phe) concentrations is critical for the management of phenylketonuria (PKU...
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Analysis of blood phenylalanine is central to the monitoring of patients with phenylketonuria (PKU) ...
Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients w...
Phenylketonuria (PKU) was the first disease to be identified by the newborn screening (NBS) program....
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Introduction: Inborn errors of metabolism (IEM) are a collective group of rare genetic disorders tha...
Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), responsibl...
Abstract Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), r...
Background In patients with Phenylketonuria (PKU) target ranges of blood phenylalanine (Phe) concent...
Background: This study investigated the agreement between various dried blood spot (DBS) and venous ...
Background/Aims: In patients with phenylketonuria (PKU), target ranges of blood phenylalanine (Phe) ...
International audienceBACKGROUND:Different pathophysiological mechanisms have been described in phen...
Monitoring phenylalanine (Phe) concentrations is critical for the management of phenylketonuria (PKU...
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Analysis of blood phenylalanine is central to the monitoring of patients with phenylketonuria (PKU) ...
Measurement of plasma and dried blood spot (DBS) phenylalanine (Phe) is key to monitoring patients w...
Phenylketonuria (PKU) was the first disease to be identified by the newborn screening (NBS) program....
Background: Reliable measurement of phenylalanine (Phe) is a prerequisite for adequate follow-up of ...
Introduction: Inborn errors of metabolism (IEM) are a collective group of rare genetic disorders tha...
Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), responsibl...
Abstract Phenylketonuria (PKU) is caused by deficient activity of phenylalanine hydroxylase (PAH), r...
Background In patients with Phenylketonuria (PKU) target ranges of blood phenylalanine (Phe) concent...
Background: This study investigated the agreement between various dried blood spot (DBS) and venous ...
Background/Aims: In patients with phenylketonuria (PKU), target ranges of blood phenylalanine (Phe) ...
International audienceBACKGROUND:Different pathophysiological mechanisms have been described in phen...